FDA Investigator Robert M Barbosa

Robert M Barbosa has conducted inspections on 160 sites in 6 countries as of 08 Feb 2022. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
160
Last Inspection Date:
08 Feb 2022
Investigator Role:
FDA Investigator
Redica ID:
100006955
Countries of Inspections:
India, United States of America, United Kingdom of Great Britain and Northern Ireland, Ireland, France, Portugal
FDA Investigators that have inspected at least one site in common with Robert M Barbosa:
Ademola O Daramola, Alan L Truong, Alan P Kurtzberg, Alexandra A Carrico, Alicia M Mozzachio, Amanda L Baskin, Anastasia M Shields, Andrace L Deyampert, Andre S Raw, Andrea D Swingle, Andrea F White, Andrew J Barrowcliff, Angel S Johnson, Anita Narula, PhD, Anita R Michael, Ann Raju Daniel, Antonio M Hampton, Art O Czabaniuk, Atul J Agrawal, Aurora Miha Trifanov, Ava M Bowman, Azza Talaat, Barbara D Bennett, Bei Y He, Benjamin J Smith, Bernard P Heidt, Bo Chi, PhD, Bonita S Chester, Brandi N Mcgrady, Brandy N Lepage, Brentley S Collins, Brian D Garthwaite, Brian J Davis, Brian M Campbell, Brian P Hendrickson, Brittany M Lowe, Brooke K Higgins, Brooke K Seeman, Burnell M Henry, Byungja E Marciante, Calvin K Cook, Carla A Norris, Carla J Lundi, Carmen M Faraianu, Caroline H Le, Catherine V Quinlan, CDR Kimberly Y Martin, CDR Rochelle B Young, RPh, MSA, Charisse K Green, Charles E Frelix, Charles I Ann, Charles L Zhou, Charles M Edwards, Charles M Spyr, Charles Yuanchia Kuo, PhD, Cheng H Yen, Cheryl A Clausen, Christian D Lynch (CDL), Chryste D Best, Colleen Thomas, PhD, Constantin Y Philopoulos, Corrine M Carter, Cristina Ausin Moreno, PhD, Cynthia Jim, CSO, Danial S Hutchison, Daniel B Arrecis, Daniel J Brown, Daniel J Gorski, Daniel J Roberts, Danny Tuntevski, Darren S Morgan, David A Paterson, David J Gasparovich, David L Duncan, Dawn C Olenjack, Deanna L Lampley, Debara R Reese, Debara Reese, Debra I Love, Denise L Burosh, Dennis Cantellops Paite, Dennis E Guilfoyle, PhD, Dennis E Swartz, Dennis R Downer, Diane L Raccasi, Dina A Tallman, Dipesh K Shah, Donald C Obenhuber, PhD, Donna K Speer, Douglas A Campbell, Douglas C Kovacs, Dr. Abhijit Raha, PhD, Dr. Barbara D Paul, PhD, Dr. Sriram Subramaniam, PhD, Dr. Zhihao Qiu (Peter), PhD, Eboni S Funderburk, Edwardstine J Reese, Edwin Jao, Edwin Melendez, Eileen A Liu, Eliezar Ramos, Elizabeth P Mayer, Emest F Bizjak, Emilie E Kahn, Emily J Orban, Enrico Joset Mangahis, Eric M Mueller, PharmD, Eric S Pittman, Erin M Miller, Esther C Broner, PhD, Etty Feller, Everard A Irish, Farhana Khan, Felix Maldonado, Frank Wackes, Gary Durbiel Goldner, Gene D Arcy, Geneve M Maxwell, Geneve M Parks, George G Calafactor, Gilbert T Salud, Guerlain Ulysse, Guo Q Shen, Gwyn G Dickinson, Hans T Meyers, Hassan Ali, Heika R Tait, Helen B Ricalde, Helen Verdel, Howard Anderson, PhD, Hyung Yul Lee, Ifueko Osemwota, Ivis L Negron, Jacob G Lutz, Jacqueline Mdiaz Albertini, Jagan Mohanr Parepally, PhD, James A Lane, James K Ireland, James N Rench, Janet L Bowen, Jazmine N Still, Jean Blackston Hill, Jeffrey A Sommers, Jeffrey D Meng, Jennifer A Kemp, Jennifer L Huntington, Jennifer L Schmidt, Jennifer R Johnson, John N Woodall, Joie A Navarrete, Jon P Antoniou, Jorge F Christian, Joris Vanloco, Jose Acruz Gonzalez, José E Meléndez, Jose M Cayuela, Jose Martinez, Jr, Jose R Hernandez, Joseph A Piechocki, Joseph R Strelnik, Joshua P Wireman, Joslyn K Brunelle, PhD, Junho Pak, Justin A Boyd, Kalavati Suvarna, PhD, Karen M Montgomery (KMM), Katherine Szestypalow, Kathryn E Ogger, Kathryn G Brown, Kelley L Clark, Kellia N Hicks, Kenneth E Felkley, Kent C Faul, Kevin D Kallander, Kevin P Foley, Kham Phommachanh, Kristina Nastovski, Kristy A Zielny, L'oreal D Fowlkes, L'oreal F Walker, Lakshmi Narasimhan, PhD, Lance Mde Souza, MBA, Larry K Austin, Lata C Mathew, PhD, Laureen F Kononen, Lauren E Burke, Lauren E Sexton, Lauren Iacono Connors, PhD, Laurimer Kuilan Torres, LCDR Sean Byrd, Leigh Anne Myers, Lequita M Mayhew, Lesley Maep Lutao, Leslie A Paul, Lewis K Antwi, Lillian S Wu, Lindsey M Schwierjohann, Lisa L Flores, Lisa M Bellows, Lisa P Oakes, Logan T Williams, Lori B Wikstrom, Luella J Rossi, Luis A Dasta, Lynda L Lanning, Makini Cobourne Duval, PhD, Marcellinus D Dordunoo, Margaret M Annes, Maria Cruz Fisher, Maria Gutierrez Lugo, PhD, Marie A Fadden, Mark G Peterson, Marlon K Turner, Martha Sullivan Myrick, Marvin D Jones, Matt D Suedkamp, Matthew B Casale, Matthew J Gretkierewicz, Meisha R Sampson, Meisha Waters, Melina Lrodriguez Upton, Melissa J Garcia, Mercy Oyugi, Miah I Schneider, Michael A Taylor, Michael E Maselli, Michael G Truchan, Michael J Kuchta, Michael L Casner, Michael L Chasey, Michael R Goga, Michael Shanks, MS, Michael Y Philopoulos, Michele L Forster, PhD, Michele L Glendenning, Michele Perry Williams, Miguel A Martinez Perez, Mihaly S Ligmond, Misty D Harvey, Mobin A Tawakkul, Monica E Caphart, Montgomery Montgomery, Karen M, Mra Davism, Mra Mcculloughj, Mra Munizn, Mra Narulaa, Muna Algharibeh, Muralidhara B Gavini, PhD, Myra K Casey, Nadeem I Chaudhry, Nailing Zhang, Nancy G Schmidt, Nancy L Neiger, Nancy L Rolli, Natalie A Mickelsen, DVM, Neal D Singletary, PhD, Neali H Lucas, Nelson, Nelson A Rodriguez, Nicholas A Violand, Nicholas L Paulin, Nicole E Knowlton, Nikki S Ramirez, Omotunde O Osunsanmi, Pablo Alcantara, Paranthaman Senthamaraikannan, Parul M Patel, Patricia A Cochran, Patricia F Hughes, PhD, Patricia H Dlugosz, Patrick B Cummings, Patrick C Klotzbuecher, Patsy J Domingo, Paul A Bonneau, Paula A Trost, Peng Zhou, Peter E Baker, Philip A Klimkewicz, Prabhu P Raju, Pratik S Upadhyay, DDC, Qiao Y Bobo, Rabia Ballica, PhD, Rafeeq A Habeeb, Rajiv R Srivastava, Ralph A Erickson, Raquel Gonzalez Rivera, Raymond R Roy, PhD, Raymond T Oji, Rebecca E Dombrowski, Rebecca K Olin, Regina T Brown, Renee L Rice, PhD, Reyes Candau Chacon, PhD, Richard H Penta, Robert Barbosa, Robert C Coleman, Robert D Tollefsen, Robert J Ham, Robert R Barbosa, Rodney G Raiford, Roger A Hartman, Roger F Zabinski, Rohn R Robertson, Ronald G Crawford, Rose Ashley, Rose Xu, Rumany C Penn, PharmD, Saied A Asbagh, Samuel H Chan, PharmD, Sandra A Boyd, Sandra A Hughes, Sangeeta M Khurana, PhD, Sanket N Patel, Sara M Onyango, Sarah B Tanksley, Sarah E Rhoades, Sarah M Meng, Sarah M Napier, Sarah Rhoades, Sargum C Sood, Sarmistha Sanyal, PhD, Satheesh Thomas, Saundrea A Munroe, Scott A Golladay, Scott R Nichols, PhD, Scott T Ballard, Sharon K Thoma, PharmD, Sidney B Priesmeyer, Simone E Pitts, Sixto M Mercado Rios, Sneha S Patel, Sri Ramakrishnaiah Yellela, PhD, Stephen J Koniers, Steven C Madzo, Steven D Kehoe, Steven E Bowen, PhD, Steven P Eastham, Susan F Laska, MS, Susan M Jackson, Susan P Bruederle, Suyang Qin, Tamil Arasu, PhD, Theodore N Sietsema, Thomas A Peter, Thomas J Arista, Thomas J Cosgrove, Thuy T Nguyen, LCDR, Tiara Nbrown Crosen, Timothy C Schell, Timothy J Schmidt, Tina M Pawlowski, Tonnie L Carter, Torrance J Slayton, Tracey Asinjen Wiersma, Tracey L Siebesma, Tracey L Taylor, Travis V Hull, Truong Xuan Nguyen (Andy), Twana R Chandler, Ucheabuchi Cchudi Nwankwor, Vaishali J Patel, Vera M Anderson, Vesa Vuniqi, Vilmary Negron Rodriguez, Wayne D Mcgrath, Wayne E Seifert, Wendy G Tan, PhD, Wenzheng Wendy Zhang, William A Warnick, William D Tingley, William G Nelson, William R Brubaker, Xiaoping Guan, Xikui Chen (nmi), PhD, Xiomara Copeland, Yangmin Ning, Yanming An, PhD, Yiwei Li, Yiyue Zhang (nmi), PhD, Yuan Chia Kuo, Yumi J Hiramine, Zachary L Stamm, Zhenzhen Liu, PhD, Zhongren Wu

Robert M Barbosa's Documents

Publish Date Document Type Title
February, 2019 FDA 483 RC Outsourcing, LLC - Form 483, 2019-02-08
December, 2011 EIR Baxter Pharmaceutical Solutions LLC - EIR, 2011-12-14
October, 2015 FDA 483 Kimball Electronics Indianapolis, Inc. - Form 483, 2015-10-16
March, 2013 EIR Inotiv, Inc. - EIR, 2013-03-08
June, 2013 FDA 483 Pharmacia & Upjohn Company LLC - Form 483, 2013-06-20
August, 2016 FDA 483 Rx Compounding Inc. - Form 483, 2016-08-19
September, 2018 FDA 483 Hetero Labs Limited - Form 483, 2018-09-28
July, 2018 FDA 483 Exelead, Inc. - Form 483, 2018-07-30
March, 2013 EIR Baxter Pharmaceutical Solutions LLC - EIR, 2013-03-14
January, 2014 FDA 483 Francis W. Price, Jr., MD - Form 483, 2014-01-17
February, 2022 FDA 483 Kimball Electronics Indianapolis, Inc. - Form 483, 2022-02-24
June, 2013 EIR Pharmacia & Upjohn Company LLC - EIR, 2013-06-21
May, 2015 FDA 483 Fresenius Kabi Oncology Limited - Form 483, 2015-05-22
November, 2011 EIR Vesta Pharmaceuticals, Inc. - EIR, 2011-11-02
March, 2013 FDA 483 Response Inotiv, Inc. - Form 483R, 2013-03-27
October, 2010 FDA 483 Blairex Laboratories, Inc - Form 483, 2010-10-18
July, 2018 FDA 483 Response Exelead, Inc. - Form 483R, 2018-08-17
May, 2015 EIR Astral SteriTech Private Limited - EIR, 2015-05-11
December, 2012 FDA 483 KP Pharmaceutical Technology, Inc. - Form 483, 2012-12-17
May, 2015 FDA 483 Response Astral SteriTech Private Limited - Form 483R, 2015-05-27
May, 2016 FDA 483 Pharmakon Long Term Care Pharmacy, Inc. - Form 483, 2016-05-11
April, 2018 FDA 483 Mac-chem Products (india) Private Limited - Form 483, 2018-04-06
June, 2010 EIR BioConvergence LLC DBA Singota Solutions - EIR, 2010-06-29
April, 2015 FDA 483 Aquestive Therapeutics - Form 483, 2015-04-03
April, 2017 FDA 483 Fresenius Kabi Oncology Limited - Form 483, 2017-04-14
October, 2015 EIR Catalent Indiana, LLC - EIR, 2015-10-02
September, 2016 EIR SIONC PHARMACEUTICALS PRIVATE LIMITED - EIR, 2016-09-01
June, 2016 FDA 483 PD Pharmatech, LLC. - Form 483, 2016-06-10
February, 2012 EIR Catalent Indiana, LLC - EIR, 2012-02-24
February, 2010 FDA 483 Nice-Pak Products, Inc. - Form 483, 2010-02-10
June, 2009 FDA 483 Exelead, Inc. - Form 483, 2009-06-17
April, 2011 FDA 483 OrBion Pharmaceuticals Private Limited - Form 483, 2011-04-07
February, 2017 FDA 483 pharMerica - Form 483, 2017-02-23
March, 2010 FDA 483 Elanco Clinton Laboratories - Form 483, 2010-03-26
June, 2016 FDA 483 Ecolab Inc. - Form 483, 2016-06-24
February, 2014 FDA 483 Applied Laboratories, Inc. - Form 483, 2014-02-18
July, 2017 FDA 483 Baxter Pharmaceutical Solutions LLC - Form 483, 2017-07-17
July, 2017 EIR Baxter Pharmaceutical Solutions LLC - EIR, 2017-07-17
May, 2012 FDA 483 Exelead, Inc. - Form 483, 2012-05-11
October, 2013 EIR Catalent Indiana, LLC - EIR, 2013-10-25
June, 2011 FDA 483 Exelead, Inc. - Form 483, 2011-06-07
July, 2018 EIR Exelead, Inc. - EIR, 2018-07-30
March, 2013 FDA 483 Baxter Pharmaceutical Solutions LLC - Form 483, 2013-03-14
October, 2013 FDA 483 Catalent Indiana, LLC - Form 483, 2013-10-25
January, 2016 EIR Labcorp Drug Development Inc. - EIR, 2016-01-20
January, 2013 EIR Sun Pharmaceutical Industries, Inc. - EIR, 2013-01-11
July, 2014 FDA 483 American Family Pharmacy, LLC - Form 483, 2014-07-21
May, 2019 FDA 483 University of Wisconsin Radiopharmaceutical Production Facility - Form 483, 2019-05-23
December, 2015 FDA 483 Response Northwind Pharmaceuticals, LLC - Form 483R, 2015-12-22
May, 2012 FDA 483 Exelead, Inc. - Form 483, 2012-05-24
August, 2012 EIR INDOCO REMEDIES LIMITED - EIR, 2012-08-23
June, 2017 FDA 483 NATURAL PHARMACEUTICAL MANUFACTURING LLC - Form 483, 2017-06-15
September, 2012 EIR American Welding & Gas, Inc. - EIR, 2012-09-27
May, 2014 FDA 483 Exelead, Inc. - Form 483, 2014-05-16
January, 2013 FDA 483 Sun Pharmaceutical Industries, Inc. - Form 483, 2013-01-11
September, 2012 FDA 483 American Welding & Gas, Inc. - Form 483, 2012-09-27
May, 2015 FDA 483 Astral SteriTech Private Limited - Form 483, 2015-05-11
September, 2011 FDA 483 Century Pharmaceuticals, Inc. - Form 483, 2011-09-16
December, 2013 FDA 483 Blairex Laboratories, Inc - Form 483, 2013-12-17
January, 2018 EIR Catalent Indiana, LLC - EIR, 2018-01-19
March, 2011 FDA 483 GLAND CHEMICALS PRIVATE LIMITED - Form 483, 2011-03-30
April, 2015 FDA 483 Response Aquestive Therapeutics - Form 483R, 2015-04-24
October, 2015 FDA 483 Catalent Indiana, LLC - Form 483, 2015-10-02
December, 2015 FDA 483 Northwind Pharmaceuticals, LLC - Form 483, 2015-12-09
September, 2009 FDA 483 Lannett Company, Inc. - Form 483, 2009-09-02
December, 2015 EIR Northwind Pharmaceuticals, LLC - EIR, 2015-12-09
May, 2014 EIR Baxter Pharmaceutical Solutions LLC - EIR, 2014-05-02
November, 2017 FDA 483 KP Pharmaceutical Technology, Inc. - Form 483, 2017-11-09
July, 2010 FDA 483 Eli Lilly and Company - Form 483, 2010-07-28
October, 2015 EIR Kimball Electronics Indianapolis, Inc. - EIR, 2015-10-16
February, 2014 EIR Applied Laboratories, Inc. - EIR, 2014-02-18
February, 2019 FDA 483 Response RC Outsourcing, LLC - Form 483R, 2019-02-28
December, 2012 EIR KP Pharmaceutical Technology, Inc. - EIR, 2012-12-17
January, 2014 EIR Francis W. Price, Jr., MD - EIR, 2014-01-17
September, 2017 FDA 483 Aurobindo Pharma Limited - Form 483, 2017-09-01
November, 2010 EIR PD Pharmatech, LLC. - EIR, 2010-11-12
August, 2013 EIR Curia Indiana, LLC - EIR, 2013-08-27
August, 2011 FDA 483 Eli Lilly and Company - Form 483, 2011-08-23
October, 2015 FDA 483 Response Catalent Indiana, LLC - Form 483R, 2015-10-02
November, 2011 FDA 483 Vesta Pharmaceuticals, Inc. - Form 483, 2011-11-02
March, 2016 FDA 483 Century Pharmaceuticals, Inc. - Form 483, 2016-03-31
February, 2012 EIR Mead Johnson & Company, LLC - EIR, 2012-02-16
August, 2016 FDA 483 Response Rx Compounding Inc. - Form 483R, 2016-09-06
April, 2013 FDA 483 Eli Lilly and Company - Form 483, 2013-04-19
November, 2014 EIR Catalent Indiana, LLC - EIR, 2014-11-07
September, 2010 FDA 483 Baxter Pharmaceutical Solutions LLC - Form 483, 2010-09-23
March, 2014 FDA 483 HIKMA FARMACEUTICA (PORTUGAL), S.A - Form 483, 2014-03-28
March, 2017 EIR Life Science Logistics LLC - EIR, 2017-05-22

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more